How to Help Your Patients Find Scopolamine in Stock: A Provider's Guide

Prescribing scopolamine in 2026 means anticipating that a significant number of your patients will not be able to fill it at their first pharmacy visit. The active shortage — driven by Padagis's market exit, Teva back orders, and a June 2025 FDA safety communication — means medication access has become part of the clinical conversation. This guide gives clinicians practical tools to reduce that burden for their patients.

Setting Patient Expectations at the Point of Prescribing

The most impactful thing you can do is tell patients upfront, at the point of prescribing, that scopolamine may be difficult to fill. Patients who learn this at the pharmacy counter — especially the day before a trip — experience unnecessary stress and often give up. A brief heads-up during the visit reframes the situation and prompts action while there's still time.

Suggested script for staff or providers:

"Scopolamine patches are in short supply right now, so your first pharmacy may not have them in stock. If that happens, please call a few other pharmacies or use medfinder.com — it calls pharmacies near you to find which ones have it, which saves you a lot of time. If you truly can't find it, call us and we'll discuss alternatives."

Practical Steps Your Practice Can Take

1. Send the Prescription to Multiple Pharmacies

Most EHR systems allow electronic prescriptions to be sent to multiple pharmacies simultaneously. By e-prescribing to two or three pharmacies in the patient's area, you increase the odds that at least one will have stock without requiring the patient to make additional phone calls. Have your staff note in the chart that multiple pharmacies were contacted.

2. Include Independent Pharmacies in Your Referral Network

Independent pharmacies often use different wholesale distributors than large chains and may access manufacturer sources that CVS, Walgreens, or Rite Aid cannot. Keep a list of local independent pharmacies that your staff can recommend when shortage drugs are involved. A single reliable independent pharmacy in your referral network can resolve many shortage situations.

3. Encourage Patients to Use medfinder

medfinder.com/providers is a service designed specifically to help patients track down hard-to-find medications. medfinder calls pharmacies near the patient to check which ones have the medication in stock, then texts the patient the results. For a medication like scopolamine where availability is highly variable and unpredictable, this kind of systematic check across many pharmacies is far more efficient than having the patient call one at a time. Learn more about medfinder for providers.

4. Allow Manufacturer Substitution in Your Prescription

If you write for brand-name Transderm Scop (Baxter), a patient may be told their pharmacy doesn't carry it — even if a generic from Rhodes or Zydus is available. Ensure your prescription includes "substitute generic permitted" or write generically ("scopolamine transdermal 1 mg/3 days"). All FDA-approved generics are bioequivalent and meet the same dosing standards.

5. Have a Pre-Built Alternative Protocol Ready

For practices that prescribe scopolamine frequently (travel medicine, anesthesiology, naval or military medicine), create a standing alternative order set so staff can issue an alternative prescription without a physician callback for every case. For motion sickness, consider:

First line: Meclizine 25 mg PO (OTC Bonine), 1 hr before travel, q24h PRN

For severe cases: Promethazine 25 mg PO q4–6h (Rx required; note sedation and avoid in patients who need to drive)

Talking to Patients About the FDA Safety Update

The June 2025 FDA Drug Safety Communication about scopolamine-associated hyperthermia means providers should briefly address thermoregulation risks during counseling — particularly for pediatric patients and patients over 60. Key counseling points to include:

Do not use heating pads, electric blankets, or other external heat sources while wearing the patch.

Remove the patch immediately if you feel unusually hot or notice decreased sweating.

Be aware that symptoms may persist after patch removal — seek care if they do.

Inform the MRI team if wearing a patch — it contains aluminum and must be removed before scanning.

Documentation Considerations

Document your patient counseling on hyperthermia risk, your consideration of the shortage when prescribing (including any alternatives offered), and whether the patient was directed to medfinder or other resources to locate the medication. This protects both the patient and the practice.

When the Shortage Changes Your Clinical Decision

For some patients, particularly those planning shorter trips or who have never tried scopolamine before, it may be entirely reasonable to start with meclizine OTC rather than pursue a time-consuming pharmacy search. Meclizine is effective for the majority of patients with mild to moderate motion sickness and is universally available. Reserve the scopolamine search for patients who have failed antihistamines previously or need 72-hour continuous coverage for a long voyage.

For a clinical summary of the shortage status and alternative protocols, see: Scopolamine Shortage: What Providers Need to Know in 2026